3 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 3 |
Follow Elritercept: new trials by email Literature Review of Elritercept trials Research Report on Elritercept
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of TAK-226 for Anemia in Japanese Patients With Lower-Risk Myelodysplastic Syndromes TAK-226 - Myelodysplastic Syndromes | Phase 2 | Recruiting | Takeda | 42 | 2026-04-22 | 2026-10-28 |
| A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis Elritercept, Ruxolitinib - Myelofibrosis | Phase 2 | Recruiting | Takeda | 135 | 2021-12-16 | 2026-02-05 |
| A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Elritercept - Myelodysplastic Syndromes, Cytopenia | Phase 2 | Recruiting | Takeda | 210 | 2020-08-19 | 2026-10-19 |
Myelodysplastic Syndromes (2) · Anemia (1) · Cytopenia (1) · Primary Myelofibrosis (1) · Thrombocytopenia (1)
Takeda (3)
Australia (2) · France (2) · Spain (2) · Brazil (1) · Czechia (1) · Germany (1) · Israel (1) · Italy (1) · Japan (1) · New Zealand (1) · South Korea (1) · United Kingdom (1) · United States (1)
2023 (2)